Cargando…

Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy

SIMPLE SUMMARY: Concurrent platinum-based chemoradiotherapy (CRT) followed by maintenance treatment with the PD-L1 inhibitor durvalumab is the most effective therapy in unresectable stage III non-small-cell lung cancer (NSCLC). However, severe toxicity of this approach may lead to an unsatisfactory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaborowska-Szmit, Magdalena, Szmit, Sebastian, Olszyna-Serementa, Marta, Badurak, Paweł, Zajda, Katarzyna, Janowicz-Żebrowska, Anna, Piórek, Aleksandra, Knetki-Wróblewska, Magdalena, Jaśkiewicz, Piotr, Płużański, Adam, Krzakowski, Maciej, Kowalski, Dariusz M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954027/ https://www.ncbi.nlm.nih.gov/pubmed/36831618 http://dx.doi.org/10.3390/cancers15041277

Ejemplares similares

Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy
por: Zaborowska-Szmit, Magdalena, et al.
Publicado: (2021)

Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer
por: Olszyna-Serementa, Marta, et al.
Publicado: (2023)

Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice
por: Knetki-Wróblewska, Magdalena, et al.
Publicado: (2023)

A case of adenoid cystic carcinoma of trachea: treatment complications and radiotherapy role
por: Piórek, Aleksandra, et al.
Publicado: (2021)

Thymic epithelial tumors: Do we know all the prognostic factors?
por: Knetki‐Wróblewska, Magdalena, et al.
Publicado: (2021)

Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer
por: Zaborowska-Szmit, Magdalena, et al.
Publicado: (2020)

Nivolumab for Previously Treated Patients with Non-Small-Cell Lung Cancer—Daily Practice versus Clinical Trials
por: Knetki-Wróblewska, Magdalena, et al.
Publicado: (2020)

Efficacy of Immunotherapy in Second-Line Treatment of KRAS-Mutated Patients with Non-Small-Cell Lung Cancer—Data from Daily Practice
por: Knetki-Wróblewska, Magdalena, et al.
Publicado: (2022)

Non-Small-Cell Lung Cancer Patients with Coexistence of High PD-L1 Expression and RET Fusion—Which Path Should We Follow? Case Reports and Literature Review
por: Knetki-Wróblewska, Magdalena, et al.
Publicado: (2022)

Do We Need TNM for Tracheal Cancers? Analysis of a Large Retrospective Series of Tracheal Tumors
por: Piórek, Aleksandra, et al.
Publicado: (2022)

Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland
por: Kowalski, Dariusz M., et al.
Publicado: (2012)

Crizotinib in the treatment of non-small-cell lung carcinoma
por: Płużański, Adam, et al.
Publicado: (2013)

Solitary fibrous tumour along with non-small-cell lung cancer and Doege-Potter syndrome
por: Piórek, Aleksandra, et al.
Publicado: (2019)

Sorafenib in progressive castrate-resistant prostate cancer. Can we talk about a new therapeutic option?
por: Zaborowska, Magdalena, et al.
Publicado: (2012)

Real-world clinical outcomes of first-generation and second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large cohort of European non-small-cell lung cancer patients
por: Pluzanski, Adam, et al.
Publicado: (2020)

The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients
por: Kucharczyk, Tomasz, et al.
Publicado: (2015)

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients
por: Krawczyk, Paweł, et al.
Publicado: (2014)

A thymoma or not a thymoma—that is the question: a case report
por: Szolkowska, Malgorzata, et al.
Publicado: (2021)

Baseline Electrocardiographic and Echocardiographic Assessment May Help Predict Survival in Lung Cancer Patients—A Prospective Cardio-Oncology Study
por: Mędrek, Sabina, et al.
Publicado: (2022)

Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?
por: Mędrek, Sabina, et al.
Publicado: (2022)

Echocardiography-Assessed Changes of Left and Right Ventricular Cardiac Function May Correlate with Progression of Advanced Lung Cancer—A Generating Hypothesis Study
por: Mędrek, Sabina, et al.
Publicado: (2022)

Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas
por: Szpechcinski, Adam, et al.
Publicado: (2022)

Diverse Action of Selected Statins on Skeletal Muscle Cells—An Attempt to Explain the Protective Effect of Geranylgeraniol (GGOH) in Statin-Associated Myopathy (SAM)
por: Jaśkiewicz, Anna, et al.
Publicado: (2019)

Intensive rehabilitation as an independent determinant of better outcome in patients with lung tumors treated by thoracic surgery
por: Glogowska, Oliwia, et al.
Publicado: (2016)

Cardiovascular Complications of Prostate Cancer Treatment
por: Wilk, Michał, et al.
Publicado: (2020)

Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
por: Koszałka, Patrycja, et al.
Publicado: (2007)

Relationship between clinical data and gene expression in the HER2/ErbB2-dependent signaling pathway in patients with acute heart failure
por: Szmit, Sebastian, et al.
Publicado: (2013)

Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment—A Cardio-Oncology Study
por: Wilk, Michał, et al.
Publicado: (2021)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
por: Gupta, Arunima, et al.
Publicado: (2014)

Impact of β-blockers on survival outcomes in patients with unresectable hepatocellular carcinoma
por: Altshuler, Ellery, et al.
Publicado: (2022)

Experimental Analysis of Aerodynamic Loads of Three-Bladed Rotor
por: Szmit, Zofia, et al.
Publicado: (2022)

Unresectable Extraskeletal Myxoid Chondrosarcoma of the Neck: Early Tumor Response to Chemoradiotherapy
por: Zaki, Mark, et al.
Publicado: (2015)

Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors
por: Wieteska-Miłek, Maria, et al.
Publicado: (2022)

Cardiac Biomarkers and Geriatric Assessment in Metastatic Castrate-Resistant Prostate Cancer During Abiraterone Acetate Therapy – A Cardio-Oncology Study
por: Wilk, Michał, et al.
Publicado: (2022)

Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?
por: Wiwanitkit, Viroj
Publicado: (2016)

The average relative dose intensity of R‐CHOP is an independent factor determining favorable overall survival in diffuse large B‐cell lymphoma patients
por: Długosz‐Danecka, Monika, et al.
Publicado: (2019)

Transcutaneous electrical acupoint stimulation to reduce opioid consumption in patients undergoing inguinal hernia repair: protocol for a randomized controlled trial
por: Agrawal, Siddarth, et al.
Publicado: (2022)

Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines
por: Gawlik, Michał, et al.
Publicado: (2023)

Matrix metalloproteinase-3 in preeclamptic and normotensive pregnancies complicated by foetal growth restriction
por: Laskowska, Marzena, et al.
Publicado: (2023)

Treatment Patterns, Testing Practices, and Outcomes in Patients with EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer in Poland: A Descriptive Analysis of National, Multicenter, Real-World Data from the REFLECT Study
por: Pluzanski, Adam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pkm6no7690j15ie5pui03v6k22